When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Zika virus infection

Evidence last reviewed: 21 Aug 2026
Topic last updated: 18 Jun 2026

Summary

Definition

History and exam

Key diagnostic factors

  • residence in/travel from endemic area
  • fever
  • maculopapular rash
  • arthralgia
  • conjunctivitis
  • features of congenital Zika syndrome (infants)
  • features of Guillain-Barre syndrome
Full details

Other diagnostic factors

  • other constitutional symptoms
  • gastrointestinal symptoms
  • retro-orbital pain
  • edema of lower limbs
  • transient hearing loss in adults
Full details

Risk factors

  • residence in/travel from endemic area
  • mosquito bites in endemic area
  • unprotected sexual contact with infected individual
  • blood transfusion from infected individual
  • sperm donation from infected individual
  • exposure to other infected body fluids
  • exposure to infected human cells/tissues
Full details

Diagnostic tests

1st tests to order

  • reverse transcriptase-polymerase chain reaction (RT-PCR)
  • serology
  • testing for other arboviruses
Full details

Tests to consider

  • prenatal ultrasound
  • amniocentesis
  • head circumference measurement (newborn)
  • newborn further evaluation
  • CT/MRI head (newborn)
  • tests for Guillain-Barre syndrome
Full details

Treatment algorithm

ACUTE

symptomatic: nonpregnant

pregnant: with possible mosquito-borne or sexual exposure

congenital Zika syndrome

Zika-associated Guillain-Barre syndrome

Contributors

Authors

Adriana Scavuzzi, MD, MSc, PhD

Coordinator Obstetrics/Gynecology

Microcephaly Working Group

Instituto de Medicina Integral Professor Fernando Figueira (IMIP)

Recife

Brazil

Disclosures

AS declares that she has no competing interests.

Acknowledgements

Dr Adriana Scavuzzi would like to gratefully acknowledge Dr Geraldo Furtado, a previous contributor to this topic.

Disclosures

GF declares they have no competing interests.

Peer reviewers

William A. Petri, Jr., MD, PhD

Chief

Division of Infectious Diseases and International Health

University of Virginia

Charlottesville

VA

Disclosures

WAP declares that he has no competing interests.

Dominic Dwyer, BSc (Med), MBBS, MD, FRACP, FRCPA

Director

Institute of Clinical Pathology and Medical Research

Pathology West

Westmead Hospital

Sydney

Australia

Declarações

DD is a member of Advisory Boards for bioCSL and GSK in antivirals and vaccines.

Chad Achenbach, MD, MPH

Assistant Professor

Division of Infectious Diseases

Northwestern University Feinberg School of Medicine

Chicago

IL

Declarações

CA declares that he has no competing interests.

Henry Wu, MD, DTM&H

Assistant Professor of Medicine

TravelWell Center

Division of Infectious Diseases

Atlanta

GA

Declarações

HW declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Adebanjo T, Godfred-Cato S, Viens L, et al. Update: interim guidance for the diagnosis, evaluation, and management of infants with possible congenital Zika virus infection - United States, October 2017. MMWR Morb Mortal Wkly Rep. 2017 Oct 20;66(41):1089-99.Texto completo  Resumo

Pan American Health Organization; World Health Organization. Provisional remarks on Zika virus infection in pregnant women: document for health care professionals. Jan 2016 [internet publication].Texto completo

World Health Organization. WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever. Jul 2025 [internet publication].Texto completo

Centers for Disease Control and Prevention. Zika virus: clinical testing and diagnosis for Zika virus disease. Nov 2025 [internet publication].Texto completo

World Health Organization. Laboratory testing for Zika virus and dengue virus infections: interim guidance. Jul 2022 [internet publication].Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Zika virus infection images
  • Diagnósticos diferenciais

    • Dengue fever
    • Chikungunya virus
    • West Nile virus
    Mais Diagnósticos diferenciais
  • Diretrizes

    • CDC Yellow Book: health information for international travel - Zika
    • WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Zika virus

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal